We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The drug is currently approved for treatment of patients with multicentric Castleman disease, a rare condition that affects the lymph nodes and related tissues. Read More
Dozens of clinical trials are being put on hold as the clinical trial industry grapples with the fallout from COVID-19. The outbreak has put the brakes on virtually all new trials being planned, except those focused on COVID-19 vaccines and treatments. Read More
The pace of research is ramping up as drugmakers and organizations accelerate efforts on COVID-19 treatment and vaccine candidates, with a number of accomplishments recently, especially for vaccines: Read More
Roche is making progress in efforts to repurpose its immunosuppressive drug Actemra (tocilizumab) for treating the coronavirus, gaining FDA approval for a phase 3 trial, the company announced Thursday. Read More